Rituxirel 500 Mg Injection

About Rituxirel 500 Mg Injection

Rituxirel 500 mg Injection is a monoclonal antibodybased anticancer medicine containing Rituximab, widely used in the treatment of certain B-cell malignancies and autoimmune disorders. It works by specifically targeting the CD20 antigen present on B-lymphocytes, leading to destruction of abnormal cells while minimizing damage to healthy tissues.

This injection is commonly prescribed by oncologists and hematologists as part of combination therapy or as a standalone treatment, depending on the patients condition and clinical protocol.

Key Composition

• Generic Name: Rituximab

• Strength: 500 mg

• Dosage Form: Injection

Therapeutic Uses

• Non-Hodgkins Lymphoma (NHL)

• Chronic Lymphocytic Leukemia (CLL)

• Rheumatoid Arthritis (in combination with methotrexate)

• Other CD20-positive B-cell disorders (as prescribed)

Mechanism of Action

Rituxirel binds to CD20 antigens on B-cells and induces cell death through immune-mediated mechanisms, helping reduce disease progression and improve treatment outcomes.

Administration

• Administered intravenously (IV infusion)

• Dosage and schedule strictly as directed by a qualified healthcare professional

• Given under medical supervision in a hospital or clinical setting

Storage Instructions

• Store at 2C to 8C

• Do not freeze

• Protect from light

Safety Information

• Prescription medicine; use only under medical supervision

• Not recommended during pregnancy unless clearly needed

• Patients should be monitored for infusion-related reactions

Advanced Monoclonal Antibody Therapy

Rituxirel 500 Mg Injection utilizes rituximab, a chimeric monoclonal antibody specifically targeting the CD20 antigen on B-lymphocytes. This targeted approach is effective in treating various hematological malignancies and autoimmune diseases, offering improved outcomes for eligible patients. Its precise action makes it a cornerstone therapy in conditions like Non-Hodgkin's Lymphoma and Rheumatoid Arthritis.


Safe and Regulated Administration

The product is administered exclusively through intravenous infusion under medical supervision, ensuring thorough monitoring for infusion reactions and optimal patient safety. Dilution in sodium chloride solution is mandated prior to administration, and the prescription-only status ensures that qualified healthcare professionals oversee the treatment process.


Strict Storage and Packaging Guidelines

Packaged in a glass vial with a flip-off seal, each unit comes individually boxed to protect its integrity. Rituxirel must be stored at 2C to 8C, protected from light, and never frozen. With a 24-month shelf life, the product maintains its efficacy and safety profile when stored correctly.